Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 03, 2022

SELL
$90.51 - $207.38 $90,781 - $208,002
-1,003 Reduced 27.74%
2,613 $239,000
Q2 2022

Jul 01, 2022

SELL
$87.94 - $101.67 $1,143 - $1,321
-13 Reduced 0.36%
3,616 $335,000
Q1 2022

Apr 01, 2022

SELL
$85.56 - $107.12 $19,507 - $24,423
-228 Reduced 5.91%
3,629 $365,000
Q4 2021

Jan 04, 2022

SELL
$97.41 - $116.74 $1,558 - $1,867
-16 Reduced 0.41%
3,857 $408,000
Q3 2021

Oct 01, 2021

BUY
$101.72 - $114.56 $203 - $229
2 Added 0.05%
3,873 $410,000
Q2 2021

Jul 01, 2021

SELL
$100.62 - $116.66 $27,368 - $31,731
-272 Reduced 6.57%
3,871 $414,000
Q1 2021

Apr 01, 2021

SELL
$95.11 - $111.11 $14,551 - $16,999
-153 Reduced 3.56%
4,143 $418,000
Q4 2020

Jan 04, 2021

BUY
$101.34 - $117.74 $506 - $588
5 Added 0.12%
4,296 $469,000
Q3 2020

Oct 01, 2020

SELL
$95.79 - $111.95 $9,291 - $10,859
-97 Reduced 2.21%
4,291 $441,000
Q2 2020

Jul 01, 2020

SELL
$90.75 - $104.91 $9,801 - $11,330
-108 Reduced 2.4%
4,388 $434,000
Q1 2020

Apr 01, 2020

SELL
$79.09 - $114.05 $14,868 - $21,441
-188 Reduced 4.01%
4,496 $408,000
Q4 2019

Jan 02, 2020

BUY
$77.9 - $98.54 $311 - $394
4 Added 0.09%
4,684 $454,000
Q3 2019

Oct 01, 2019

SELL
$74.21 - $82.92 $9,202 - $10,282
-124 Reduced 2.58%
4,680 $369,000
Q2 2019

Jul 01, 2019

BUY
$68.24 - $75.87 $477 - $531
7 Added 0.15%
4,804 $362,000
Q1 2019

Apr 01, 2019

BUY
$65.72 - $71.66 $51,064 - $55,679
777 Added 19.33%
4,797 $332,000
Q4 2018

Jan 02, 2019

BUY
$61.31 - $73.73 $674 - $811
11 Added 0.27%
4,020 $262,000
Q3 2018

Oct 02, 2018

BUY
$71.66 - $82.93 $1,361 - $1,575
19 Added 0.48%
4,009 $292,000
Q2 2018

Jul 02, 2018

SELL
$58.93 - $74.24 $52,801 - $66,519
-896 Reduced 18.34%
3,990 $284,000
Q1 2018

Apr 02, 2018

BUY
$54.51 - $65.8 $2,561 - $3,092
47 Added 0.97%
4,886 $291,000
Q4 2017

Jan 02, 2018

BUY
$52.25 - $56.32 $10,972 - $11,827
210 Added 4.54%
4,839 $267,000
Q3 2017

Oct 02, 2017

BUY
$49.7 - $54.38 $230,061 - $251,725
4,629
4,629 $243,000

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $84.7B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Park National Corp Portfolio

Follow Park National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.